Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.75 GBX | -3.12% | +14.81% | -11.43% |
May. 08 | Hellenic Dynamics and Ondine Biomedical raise funds | AN |
May. 03 | Ondine Biomedical shares rise on fundraise to advance Steriwave | AN |
Sales 2023 * | 1.18M 867K | Sales 2024 * | 2.6M 1.9M | Capitalization | 37.45M 27.44M |
---|---|---|---|---|---|
Net income 2023 * | -15M -10.99M | Net income 2024 * | -18M -13.19M | EV / Sales 2023 * | 30.7 x |
Net cash position 2023 * | 1.1M 806K | Net cash position 2024 * | 3.8M 2.78M | EV / Sales 2024 * | 13 x |
P/E ratio 2023 * |
-1.65
x | P/E ratio 2024 * |
-2.67
x | Employees | 18 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 30.92% |
Latest transcript on Ondine Biomedical Inc.
1 day | -3.13% | ||
1 week | +14.81% | ||
Current month | +44.19% | ||
1 month | +31.91% | ||
3 months | -20.51% | ||
6 months | -6.06% | ||
Current year | -11.43% |
Managers | Title | Age | Since |
---|---|---|---|
Carolyn Cross
FOU | Founder | 62 | 96-09-08 |
Nicolas Loebel
PSD | President | 64 | 04-02-29 |
Bill Kanz
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Craig Tooman
BRD | Director/Board Member | 58 | 21-12-06 |
Carolyn Cross
FOU | Founder | 62 | 96-09-08 |
Nicolas Loebel
PSD | President | 64 | 04-02-29 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 7.75 | -3.12% | 267,191 |
24-05-24 | 8 | +6.67% | 85,242 |
24-05-23 | 7.5 | +11.11% | 440,978 |
24-05-22 | 6.75 | 0.00% | 90,662 |
24-05-21 | 6.75 | 0.00% | 205,851 |
Delayed Quote London S.E., May 28, 2024 at 11:35 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.43% | 28.34M | |
-7.38% | 181B | |
-0.46% | 108B | |
-6.98% | 66.12B | |
+2.65% | 50.65B | |
+5.27% | 43.11B | |
+3.49% | 40.74B | |
+19.92% | 31.6B | |
+16.38% | 25.56B | |
-7.00% | 24.16B |
- Stock Market
- Equities
- OBI Stock